A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transplantation

Autor: Kean, Leslie S., Burns, Linda J *, Kou, Tzuyung Douglas *, Bond, Christopher *, Kapikian, Roxanne *, Lozenski, Karissa *, Tang, Xiao-Ying *, Zhang, Mei-Jie *, Hemmer, Michael T *, Connolly, Sean E *, Polinsky, Martin *, Gomez, Andres *, Pasquini, Marcelo C
Zdroj: In Blood 15 November 2022 140 Supplement 1:1373-1375
Databáze: ScienceDirect